7241 - 7250 of 8404 Results
Title
Year
-
OPENTitle: Can Parkinson’s disease be cured by stimulating neurogenesis?Journal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 125Issue #: 3Start Page: 978End Page: 980Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci80822Best OA location URL: http://www.jci.org/articles/view/80822/files/pdfCitation Count: 10
- Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter2015OPENTitle: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence ReporterJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 5Start Page: 1188End Page: 1197Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/cb5010417Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927027Citation Count: 54
-
RESTRICTEDTitle: Molecular imaging of levodopa-induced dyskinesiasJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 72Issue #: 11Start Page: 2107End Page: 2117Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-015-1854-xCitation Count: 17
-
OPENTitle: Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 129Issue #: 4Start Page: 565End Page: 583Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-015-1395-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-015-1395-2.pdfCitation Count: 47
-
OPENTitle: Novel Antioxidants Protect Mitochondria from the Effects of Oligomeric Amyloid Beta and Contribute to the Maintenance of Epigenome FunctionJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 6Issue #: 4Start Page: 588End Page: 598Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/cn500323qBest OA location URL: https://europepmc.org/articles/pmc4838453?pdf=renderCitation Count: 11
-
OPENTitle: Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer’s disease patientsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 591Issue #:Start Page: 19End Page: 24Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2015.02.013Best OA location URL: https://europepmc.org/articles/pmc4382517?pdf=renderCitation Count: 11
-
RESTRICTEDTitle: Cell penetrating peptide-mediated transport enables the regulated secretion of accumulated cargoes from mast cellsJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 202Issue #:Start Page: 108End Page: 117Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jconrel.2015.02.005Citation Count: 19
-
OPENTitle: Identification of Synaptosomal Proteins Binding to Monomeric and Oligomeric α-SynucleinJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 10Issue #: 2Start Page: e0116473End Page: e0116473Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0116473Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0116473&type=printableCitation Count: 68
- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study2015OPENTitle: Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 138Issue #: 4Start Page: 963End Page: 973Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awu409Best OA location URL: https://academic.oup.com/brain/article-pdf/138/4/963/13798742/awu409.pdfCitation Count: 151
-
RESTRICTEDTitle: Effect of selective LRRK2 kinase inhibition on nonhuman primate lungJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 273Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aaa3634Citation Count: 331